Prostate cancer progression: Sodium salicylate, the active metabolite of aspirin inhibits nuclear factor-kappa B (NFkB) pathway

Olaniyi Ogundiya, Helen Whiteland, U. K. Shah, O. Bodger, H. Haboubi, H. Kynaston, S. Doak

Research output: Contribution to conferenceAbstractpeer-review

Fingerprint

Dive into the research topics of 'Prostate cancer progression: Sodium salicylate, the active metabolite of aspirin inhibits nuclear factor-kappa B (NFkB) pathway'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science